NCT06839300View on ClinicalTrials.gov

The International Spinal Cord Injury Blood Biomarker Longitudinal Evaluation (I-SCRIBBLE) Study

Not yet recruitingOBSERVATIONAL

Enrollment

260

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

December 1, 2029

Study Completion Date

December 1, 2029

Conditions

Spinal Cord Injury

All Listed Sponsors

lead

AO Foundation, AO Spine

OTHER

NCT06839300 - The International Spinal Cord Injury Blood Biomarker Longitudinal Evaluation (I-SCRIBBLE) Study | Biotech Hunter | Biotech Hunter